Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2001 | 12-2000 | 06-2000 | 12-1999 | 06-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,174 | N/A | -8,722 | N/A | -9,996 |
| Depreciation Amortization | 3,729 | 3,280 | 3,285 | 3,220 | 3,224 |
| Accounts receivable | -3,204 | N/A | -1,101 | N/A | -859 |
| Accounts payable and accrued liabilities | 5,395 | N/A | N/A | N/A | N/A |
| Other Working Capital | -745 | 22,090 | 22,099 | -7,400 | -7,401 |
| Other Operating Activity | -1,776 | 500 | 1,603 | 30 | 894 |
| Operating Cash Flow | $-3,775 | $25,870 | $17,164 | $-4,150 | $-14,138 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,255 | -4,600 | -4,602 | -370 | -371 |
| Purchase Of Investment | -252,035 | N/A | -24,734 | N/A | -291,707 |
| Sale Of Investment | 172,206 | N/A | 25,001 | N/A | 296,584 |
| Other Investing Activity | 0 | 260 | 0 | 4,870 | 0 |
| Investing Cash Flow | $-85,084 | $-4,340 | $-4,336 | $4,500 | $4,506 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 68,581 | N/A | 37,982 | N/A | 570 |
| Other Financing Activity | 0 | 37,980 | 0 | 450 | -129 |
| Financing Cash Flow | $68,581 | $37,980 | $37,982 | $450 | $441 |
| Beginning Cash Position | 56,215 | N/A | 5,405 | N/A | 14,595 |
| End Cash Position | 35,937 | N/A | 56,215 | N/A | 5,405 |
| Net Cash Flow | $-20,278 | $59,510 | $50,810 | $800 | $-9,190 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,775 | 25,870 | 17,164 | -4,150 | -14,138 |
| Capital Expenditure | -5,255 | N/A | -4,617 | N/A | -3,976 |
| Free Cash Flow | -9,030 | 25,870 | 12,546 | -4,150 | -18,113 |